Table 3. PHQ-9 Question 9 participant responses among participants screened during the suicidality protocol implementation period.

		Telephone PHQ-9 Q9 N (%)	Depressive severity	N (%)
Baseline		0*		0*
	0 days	0 (0.00)	No depression	0 (0.00)
	1–7 days	0 (0.00)	Mild	0 (0.00)
	8–12 days	0 (0.00)	Moderate	0 (0.00)
	13–14 days	0 (0.00)	Moderately severe	0 (0.00)
	Missing	0 (0.00)	Severe	0 (0.00)
			Missing	0 (0.00)
3 month follow-up		83		83
	0 days	80 (96.39)	No depression	46 (55.42)
	1–7 days	2 (2.41)	Mild	33 (39.76)
	8–12 days	1 (1.20)	Moderate	4 (4.82)
	13–14 days	0 (0.00)	Moderately severe	0 (0.00)
	Missing	0 (0.00)	Severe	0 (0.00)
			Missing	0 (0.00)
6 month follow-up		234		234
	0 days	231 (98.72)	No depression	133 (56.84)
	1–7 days	3 (1.28)	Mild	73 (31.20)
	8–12 days	0 (0.00)	Moderate	21 (8.97)
	13–14 days	0 (0.00)	Moderately severe	5 (2.14)
	Missing	0 (0.00)	Severe	0 (0.00)
			Missing	2 (0.85)
12 month follow-up		285		285
	0 days	279 (97.89)	No depression	168 (58.95)
	1–7 days	3 (1.05)	Mild	93 (32.63)
	8–12 days	0 (0.00)	Moderate	13 (4.56)
	13–14 days	3 (1.05)	Moderately severe	5 (1.75)
	Missing	0 (0.00)	Severe	4 (1.40)
			Missing	2 (0.70)

*No new patients were enrolled during the study period due to the pandemic

**n = 2 participants are missing overall PHQ-9 score